查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1212647

人类胚胎干细胞(人类胚胎干细胞:hESC)研究的全球市场

Human Embryonic Stem Cell (hESC) Research
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

人类胚胎干细胞(hESC)研究的全球市场2030年前将达到13亿美元

在COVID-19后改变的商务环境中，2022年7亿5,740万美元的人类胚胎干细胞(hESC)研究的全球市场2030年前将达到13亿美元的规模，在2022年～2030年分析期间预计将以6.5％的年复合成长率增长。本报告所分析之市场区隔之一的再生医疗将记录年复合成长率6.6％，到分析期间结束时将达到8亿9,230万美元。考虑疫情后的復苏，干细胞生物学研究领域今后8年的年复合成长率将修正为7.4。

美国市场估算为2亿2,160万美元，中国则将以年复合成长率6.1％的速度成长

美国的人类胚胎干细胞(hESC)研究市场在2022年估算为2亿2,160万美元。作为世界第2大经济大国的中国，在2022年～2030年年复合成长率预计将为6.1％，2030年达到2亿1,930万美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年预计将各以5.8％和5.4％的速度成长。在欧洲市场中，德国预计将以年复合成长率5％成长。

调查对像企业范例

  • Astellas Institute of Regenerative Medicine
  • Asterias Biotherapeutics, Inc.
  • BD Biosciences
  • Cell Cure Neurosciences Ltd.
  • Cellular Dynamics International
  • GE Healthcare
  • PerkinElmer, Inc.
  • Reliance Life Sciences Ltd.
  • Research & Diagnostics Systems, Inc.
  • STEMCELL Technologies, Inc.
  • Stemina Biomarker Discovery, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • Thermo Fischer Scientific Inc.
  • UK Stem Cell Bank
  • ViaCyte, Inc.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP-6831

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$757.4 Million in the year 2022, is projected to reach a revised size of US$1.3 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2022-2030. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$892.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $221.6 Million, While China is Forecast to Grow at 6.1% CAGR

The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$221.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$219.3 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Select Competitors (Total 24 Featured):

  • Astellas Institute of Regenerative Medicine
  • Asterias Biotherapeutics, Inc.
  • BD Biosciences
  • Cell Cure Neurosciences Ltd.
  • Cellular Dynamics International
  • GE Healthcare
  • PerkinElmer, Inc.
  • Reliance Life Sciences Ltd.
  • Research & Diagnostics Systems, Inc.
  • STEMCELL Technologies, Inc.
  • Stemina Biomarker Discovery, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • Thermo Fischer Scientific Inc.
  • UK Stem Cell Bank
  • ViaCyte, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Stem Cells Research: A Sunrise Sector in Biotechnology Arena
    • Human Embryonic Stem Cells - An Introduction
    • Embryonic Stem Cells - Sources and Cell Culture
    • Comparison on Adult and Embryonic Stem Cells
    • Advantages and Drawbacks of Various Stem Cells
    • Recent Market Activity
    • Human Embryonic Stem Cells - The Market Perspective
    • Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014
    • Teratomas - No Longer an Impediment to Stem Cell Therapy Development
    • Human Embryonic and Induced Pluripotent Stem Cell Research Trends
    • Human Embryonic Stem Cell Research: Key Statistical Highlights
    • Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013
    • Haploid Human Embryonic Stem Cell Line: The New Frontier
    • Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC
    • Human Embryonic Stem Cell (hESC) Research - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • Astellas Institute of Regenerative Medicine (US)
    • Asterias Biotherapeutics, Inc. (US)
    • BD Biosciences (US)
    • Cell Cure Neurosciences Ltd. (Israel)
    • Cellular Dynamics International (US)
    • GE Healthcare (UK)
    • MilliporeSigma (US)
    • PerkinElmer, Inc. (US)
    • Reliance Life Sciences Ltd. (India)
    • Research & Diagnostics Systems, Inc. (US)
    • SABiosciences Corp. (US)
    • STEMCELL Technologies, Inc. (Canada)
    • Stemina Biomarker Discovery, Inc. (US)
    • Takara Bio, Inc. (Japan)
    • TATAA Biocenter AB (Sweden)
    • Thermo Fisher Scientific, Inc. (US)
    • UK Stem Cell Bank (UK)
    • ViaCyte, Inc. (US)
    • Vitrolife AB (Sweden)
  • 3. MARKET TRENDS & DRIVERS
    • Issues Hindering Development of hESC Research
    • Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs
    • Ethical Issues and Technical Hurdles Bog Down hESC Research
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stem Cell Biology Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Stem Cell Biology Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Human Embryonic Stem Cell (hESC) Research Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 13: USA 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 15: Canada 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • JAPAN
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 16: Japan Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 17: Japan 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • CHINA
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 18: China Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 19: China 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • EUROPE
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: Europe 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: Europe 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • FRANCE
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 24: France Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: France 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • GERMANY
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 26: Germany Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Germany 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • ITALY
    • TABLE 28: Italy Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Italy 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • UNITED KINGDOM
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 30: UK Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: UK 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Rest of Europe 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Asia-Pacific 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 36: Rest of World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Rest of World 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030

IV. COMPETITION